TargetCool is indicated for the temporary reduction of pain, swelling, inflammation, and hematoma from minor surgical procedures.
CoolHealth is entering the U.S. market with TargetCool.
Leveraging tuneable cooling technology, TargetCool rapidly cools the skin, allowing providers to specifically set a “target” skin temperature down to the exact degree and second
This allows providers to combine TargetCool with other needle-based procedures to minimize pain, bruising, inflammation, and hematoma that may occur post-procedure.
TargetCool has been proven to provide temporary analgesia to the skin for needle-based procedures in aesthetics such as dermal fillers, toxins, and Platelet-rich plasma (PRP) injections to improve patient comfort and reduce pain-related anxiety. TargetCool can also reduce bruising, inflammation, and swelling post-procedure.
Moreover, TargetCool’s rapidity obviates the need for time-consuming traditional methods for numbing treatment areas, such as topical creams, thus reducing patient wait-times and streamlining practice workflows.
“The TargetCool device is an easy-to-use system that has quickly become my go-to for pain management for various cosmetic procedures,” says Gary Goldenberg, M.D., a dermatologist in New York City, in a news release. “Having the option to minimize post-procedure bruising while increasing patient comfort has elevated the standard of care that I am able to provide patients.”
TargetCool was created by South Korean mechanical engineer,Dr. Gun-Ho Kim. “We truly believe that TargetCool will change the face of cooling,” Dr. Kim says. “This is the first time we have had precise control over cooling temperature and duration. TargetCool is optimizing treatments for a variety of conditions, and creating unique, new treatment possibilities.”
